image
Healthcare - Medical - Diagnostics & Research - NASDAQ - IE
$ 190.02
0.206 %
$ 15.3 B
Market Cap
19.94
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Mar, 2, 2025.

The intrinsic value of one ICLR stock under the worst case scenario is HIDDEN Compared to the current market price of 190 USD, ICON Public Limited Company is HIDDEN

This DCF valuation model was last updated on Mar, 2, 2025.

The intrinsic value of one ICLR stock under the base case scenario is HIDDEN Compared to the current market price of 190 USD, ICON Public Limited Company is HIDDEN

This DCF valuation model was last updated on Mar, 2, 2025.

The intrinsic value of one ICLR stock under the best case scenario is HIDDEN Compared to the current market price of 190 USD, ICON Public Limited Company is HIDDEN

2. FUNDAMENTAL ANALYSIS
FINANCIALS
8.28 B REVENUE
1.99%
1.1 B OPERATING INCOME
14.82%
791 M NET INCOME
29.26%
1.29 B OPERATING CASH FLOW
10.82%
-267 M INVESTING CASH FLOW
-17.71%
-837 M FINANCING CASH FLOW
0.81%
2.04 B REVENUE
0.55%
297 M OPERATING INCOME
4.06%
260 M NET INCOME
31.89%
338 M OPERATING CASH FLOW
-15.98%
-68.9 M INVESTING CASH FLOW
44.60%
-404 M FINANCING CASH FLOW
-313.14%
Balance Sheet ICON Public Limited Company
image
Current Assets 3.53 B
Cash & Short-Term Investments 539 M
Receivables 2.69 B
Other Current Assets 303 M
Non-Current Assets 13.3 B
Long-Term Investments 57.9 M
PP&E 530 M
Other Non-Current Assets 12.8 B
Current Liabilities 2.8 B
Accounts Payable 173 M
Short-Term Debt 29.8 M
Other Current Liabilities 2.59 B
Non-Current Liabilities 4.56 B
Long-Term Debt 3.54 B
Other Non-Current Liabilities 1.02 B
EFFICIENCY
Earnings Waterfall ICON Public Limited Company
image
Revenue 8.28 B
Cost Of Revenue 5.85 B
Gross Profit 2.44 B
Operating Expenses 1.34 B
Operating Income 1.1 B
Other Expenses 306 M
Net Income 791 M
RATIOS
29.42% GROSS MARGIN
29.42%
13.26% OPERATING MARGIN
13.26%
9.56% NET MARGIN
9.56%
8.31% ROE
8.31%
4.69% ROA
4.69%
7.08% ROIC
7.08%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis ICON Public Limited Company
image
Net Income 791 M
Depreciation & Amortization 512 M
Capital Expenditures -168 M
Stock-Based Compensation 45.9 M
Change in Working Capital -18.8 M
Others -72.1 M
Free Cash Flow 1.12 B
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets ICON Public Limited Company
image
Wall Street analysts predict an average 1-year price target for ICLR of $362 , with forecasts ranging from a low of $295 to a high of $390 .
ICLR Lowest Price Target Wall Street Target
295 USD 55.25%
ICLR Average Price Target Wall Street Target
362 USD 90.30%
ICLR Highest Price Target Wall Street Target
390 USD 105.24%
4. DIVIDEND ANALYSIS
5. COMPETITION
6. Ownership
Insider Ownership ICON Public Limited Company
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
7. News
Shareholders of ICON Public Limited Company Should Contact Levi & Korsinsky Before April 11, 2025 to Discuss Your Rights – ICLR NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in ICON Public Limited Company ("ICON " or the "Company") (NASDAQ: ICLR) of a class action securities lawsuit. globenewswire.com - 1 week ago
ICON plc (ICLR) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit LOS ANGELES , Feb. 21, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to ICON plc ("ICON" or the "Company") (NASDAQ: ICLR) have opportunity to lead the securities fraud class action lawsuit. prnewswire.com - 1 week ago
Investors Who Lost Money on ICON Public Limited Company (ICLR) Should Contact Levi & Korsinsky About Pending Class Action - ICLR NEW YORK, NY / ACCESS Newswire / February 21, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/icon-public-limited-company-lawsuit-submission-form?prid=131352&wire=1 or contact Joseph E. Levi, Esq. accessnewswire.com - 1 week ago
A Lawsuit Has Been Filed Against ICON Public Limited Company For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm LOS ANGELES, CA / ACCESS Newswire / February 21, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company ("Icon" or "the Company") (NASDAQ:ICLR) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 27, 2023 and October 23, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before April 11, 2025. accessnewswire.com - 1 week ago
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 11, 2025 in ICON Lawsuit - ICLR NEW YORK, NY / ACCESS Newswire / February 21, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/icon-public-limited-company-lawsuit-submission-form?prid=131315&wire=1 or contact Joseph E. Levi, Esq. accessnewswire.com - 1 week ago
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ICON Public Limited Company of Class Action Lawsuit and Upcoming Deadlines - ICLR NEW YORK, NY / ACCESS Newswire / February 21, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against ICON Public Limited Company ("Icon" or the "Company") (NASDAQ:ICLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. accessnewswire.com - 1 week ago
ICON Public Limited Company Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 11, 2025 to Discuss Your Rights - ICLR NEW YORK, NY / ACCESS Newswire / February 21, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/icon-public-limited-company-lawsuit-submission-form?prid=131263&wire=1 or contact Joseph E. Levi, Esq. accessnewswire.com - 1 week ago
ICLR Class Action Lawsuit Reminder: Kessler Topaz Meltzer & Check, LLP Reminds ICON Public Limited Company (ICLR) Investors that a Securities Fraud Class Action Lawsuit Has Been Filed RADNOR, Pa., Feb. 21, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against ICON Public Limited Company (“ICON”) (NASDAQ: ICLR) on behalf of all purchasers of ICON ordinary shares between July 27, 2023 and October 23, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is April 11, 2025. globenewswire.com - 1 week ago
Investors Who Lost Money on ICON Public Limited Company (ICLR) Should Contact Levi & Korsinsky About Pending Class Action - ICLR NEW YORK, NY / ACCESS Newswire / February 21, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/icon-public-limited-company-lawsuit-submission-form?prid=131180&wire=1 or contact Joseph E. Levi, Esq. accessnewswire.com - 1 week ago
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 11, 2025 in ICON Public Limited Company Lawsuit - ICLR NEW YORK, NY / ACCESS Newswire / February 21, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/icon-public-limited-company-lawsuit-submission-form?prid=131155&wire=1 or contact Joseph E. Levi, Esq. accessnewswire.com - 1 week ago
ICLR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ICON PLC Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! NEW YORK, NY / ACCESS Newswire / February 21, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ICON PLC ("ICON" or "the Company") (NASDAQ:ICLR) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired ICON securities between July 27, 2023 and October 23, 2024, both dates inclusive (the "Class Period"). accessnewswire.com - 1 week ago
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 11, 2025 in ICON Public Limited Company Lawsuit - ICLR NEW YORK , Feb. 21, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in ICON Public Limited Company ("ICON " or the "Company") (NASDAQ: ICLR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of ICON  investors who were adversely affected by alleged securities fraud between July 27, 2023 and October 23, 2024. prnewswire.com - 1 week ago
8. Profile Summary

ICON Public Limited Company ICLR

image
COUNTRY IE
INDUSTRY Medical - Diagnostics & Research
MARKET CAP $ 15.3 B
Dividend Yield 0.00%
Description ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.
Contact South County Business Park, Dublin, 18 https://www.iconplc.com
IPO Date May 15, 1998
Employees 42250
Officers Mr. David Green Vice President of Marketing Mr. Barry Balfe Chief Operating Officer Mr. Thomas N. O'Leary Chief Information Officer Ms. Niamh Murphy Director of Corporate Communications Mr. Joe Cronin Chief Human Resources Officer Mr. Nigel Clerkin A.C.A. Chief Financial Officer Mr. Jonathan Andrew Curtain A.C.A. Senior Vice President of Corporate & Commercial Finance Mr. Diarmaid Cunningham Chief Administrative Officer, General Counsel & Company Secretary Dr. Steven A. Cutler MBA, Ph.D. Chief Executive Officer & Director Dr. John Climax Ph.D. Founder & Independent Non-Executive Director